WHO ICTRP trial
A non-invasive swallowable device for weight loss and obesity-related…
ISRCTN53040076 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN53040076 |
|---|---|
| Public title | A non-invasive swallowable device for weight loss and obesity-related comorbidities |
| Scientific title | Study on a non-invasive swallowable device for weight loss and obesity-related comorbidities in overweight and obese patients |
| Primary sponsor | University of Rome - La Sapienza (Italy) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Italy |
| Conditions | Obesity, overweight Nutritional, Metabolic, Endocrine |
| Interventions | A new intragastric balloon, Obalon® Gastric Balloons (OGB) (ObalonTherapeutics, Inc., Carlsbad, San Diego, California) will be inserted. Obalon is a gas-filled balloon with a maximal volume of 250 ml. It is compressed, folded, and fitted in… |
| Registration date | Oct 14, 2013 |
| Target size | 200 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: